Skip to main content
  • ASM Journals
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Latest Articles
    • COVID-19 Research and News from ASM Journals
    • mSphere of Influence: Commentaries from Early Career Microbiologists
    • Archive
  • Topics
    • Applied and Environmental Science
    • Clinical Science and Epidemiology
    • Ecological and Evolutionary Science
    • Host-Microbe Biology
    • Molecular Biology and Physiology
    • Therapeutics and Prevention
  • For Authors
    • Getting Started
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About mSphere
    • Editor in Chief
    • Board of Editors
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • ASM Journals
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
mSphere
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Latest Articles
    • COVID-19 Research and News from ASM Journals
    • mSphere of Influence: Commentaries from Early Career Microbiologists
    • Archive
  • Topics
    • Applied and Environmental Science
    • Clinical Science and Epidemiology
    • Ecological and Evolutionary Science
    • Host-Microbe Biology
    • Molecular Biology and Physiology
    • Therapeutics and Prevention
  • For Authors
    • Getting Started
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About mSphere
    • Editor in Chief
    • Board of Editors
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
Research Article | Host-Microbe Biology

Next-Generation Sequencing Combined with Specific PCR Assays To Determine the Bacterial 16S rRNA Gene Profiles of Middle Ear Fluid Collected from Children with Acute Otitis Media

Saara Sillanpää, Lenka Kramna, Sami Oikarinen, Markku Sipilä, Markus Rautiainen, Janne Aittoniemi, Jussi Laranne, Heikki Hyöty, Ondrej Cinek
Paul D. Fey, Editor
Saara Sillanpää
aDepartment of Otorhinolaryngology and Head and Neck Surgery, Tampere University Hospital and School of Medicine, University of Tampere, Tampere, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lenka Kramna
bDepartment of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sami Oikarinen
cDepartment of Virology, School of Medicine, University of Tampere, Tampere, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markku Sipilä
aDepartment of Otorhinolaryngology and Head and Neck Surgery, Tampere University Hospital and School of Medicine, University of Tampere, Tampere, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus Rautiainen
aDepartment of Otorhinolaryngology and Head and Neck Surgery, Tampere University Hospital and School of Medicine, University of Tampere, Tampere, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janne Aittoniemi
dFimlab Laboratories, Tampere, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jussi Laranne
aDepartment of Otorhinolaryngology and Head and Neck Surgery, Tampere University Hospital and School of Medicine, University of Tampere, Tampere, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heikki Hyöty
cDepartment of Virology, School of Medicine, University of Tampere, Tampere, Finland
dFimlab Laboratories, Tampere, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ondrej Cinek
bDepartment of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul D. Fey
University of Nebraska Medical Center
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/mSphere.00006-17
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Supplemental Material
  • FIG 1
    • Open in new tab
    • Download powerpoint
    FIG 1

    Bacteria found in AOM samples and strengths of their signals. The vertical axis shows individual samples: /2, second sample from the subject; PERF, sample from perforation; TS, sample from tympanostomy tube; other samples are from myringotomy; c, culture; neg., culture negative; Sp, S. pneumoniae; Hi, H. influenzae; Mc, M. catarrhalis; Sa, Staphylococcus aureus; other, other bacteria. The horizontal axis shows the nine most abundant species or genera that exceeded 3% of the total sample sequencing signal in at least two AOM samples. The intersections are the relative abundances of the total sequencing signal as percentages (rounded to the nearest integer). Taxa comprising <3% of the total sample sequencing signal were disregarded. The assignation of species by 16S rRNA gene profiling is simplified, since the 16S profiling of the V4 region could not distinguish between closely related species in several instances, as follows. (i) S. pneumoniae and the less frequent S. pseudopneumoniae; the latter is commonly (mis)identified as S. pneumoniae by clinical microbiology laboratories worldwide. The sequence of the profiled V4 region of the 16S rRNA gene is also closely related to those of several other streptococci. (ii) H. influenzae and the less frequent H. haemolyticus; the latter could be excluded in culture-positive cases by its beta hemolysis. (iii) M. catarrhalis and the less frequent Moraxella nonliquefaciens; the two could be differentiated only by classic microbiological techniques, including differences in typical antibiograms. Finally, (iv) the 16S profiles in the V4 region are identical in many Staphylococci; please see the text for methods that disentangled the signals.

  • FIG 2
    • Open in new tab
    • Download powerpoint
    FIG 2

    Quantities of the bacteria assessed using the proportions within the individual sample profiles. Negs, count of samples that were negative for the bacterium in the 16S profiling, i.e., had a quantity lower than 3% of the profile signal.

  • FIG 3
    • Open in new tab
    • Download powerpoint
    FIG 3

    Comparison of detection by specific real-time PCR and by 16S profiling. Horizontal axis, threshold cycle of the respective specific PCR; vertical axis, proportion of the overall profiling signal within the sample. Note that the V4 sequence of Streptococcus pneumoniae is nearly identical to those of several further streptococci (e.g., Streptococcus dentisani, Streptococcus tigurinus, Streptococcus oralis, Streptococcus mitis, and Streptococcus infantis). These are most likely present in several samples, denoted by crosses along the vertical axis of the top left panel: here, the pneumococcus-specific real-time PCR test using the autolysin gene (lytA) is negative, but the weak signal in 16S profiling indicates the presence of these streptococci.

  • FIG 4
    • Open in new tab
    • Download powerpoint
    FIG 4

    Workflow of the study. *, data from specific PCR tests of these pathogens come from our previous study (12).

Tables

  • Figures
  • Supplemental Material
  • TABLE 1

    Bacteria found in the 16S profiles

    Finding in the bacterial profileaNo. of samples positive for the species (n = 90)
    No. of positive samples% of all samples
    Streptococcus pneumoniae 2831
        As a dominant pathogenb1416
        Sole finding but <50% of signalc33.3
        Nondominant part of mixed florad1112
    Haemophilus influenza 2427
        As a dominant pathogen1517
        Sole finding but <50% of signal33.3
        Nondominant part of mixed flora66.7
    Moraxella catarrhalis 1820
        As a dominant pathogen55.6
        Sole finding but <50% of signal44.4
        Nondominant part of mixed flora910
    Staphylococcus spp.2123
        As a dominant pathogen33.3
        Sole finding but <50% of signal66.7
        Nondominant part of mixed flora1213
    Turicella otitidis 55.6
        As a dominant pathogen22.2
        Sole finding but <50% of signal11.1
        Nondominant part of mixed flora22.2
    Alloiococcus otitidis 33.3
        As a dominant pathogen00
        Sole finding but <50% of signal00
        Nondominant part of mixed flora33.3
    Other bacteria not listed above1416
        As a dominant pathogen00
        Sole finding but <50% of signal3e3.3
        Nondominant part of mixed flora11f12
    No clear bacterial finding1416
        No bacterium found1112
        Undetermined species, <5% of signal33.3
    • ↵a The bacteria originating from the PCR components (Taq polymerase) are not shown.

    • ↵b A dominant pathogen was defined as a bacterium that makes up half or more of the total 16S rRNA gene profile.

    • ↵c Bacterium occupying 3.0 to 49% of the sequencing signal; no other bacteria were detectable over the threshold 3.0% signal except the contaminant signal from Taq polymerase.

    • ↵d Bacterium occupying 3 to 49% of the sequencing signal; also, other bacteria were present in the profile at >3.0%.

    • ↵e Prevotella melaninogenica (4% in sample from patient 41 and 6% in sample from patient 48) and undetermined Sphingobacterium (8% in patient 72). All three samples were taken by myringotomy.

    • ↵f Prevotella melaninogenica (31% of the profile of sample from patient 73, 3% in patient 22, and 4% in patient 50), Veillonella dispar (20% in patient 73 and 10% in patient 72), Veillonella montpellierensis (13% in patient 67, 6% in patient 73, and 4% in patient 2), Lactococcus lactis (7% in patient 15 and 7% in second sample from patient 59), Corynebacterium tuberculostearicum (4% from patient 50 and 3% from patient 70, both in samples with dominant S. pneumoniae), and undetermined Sphingobacterium.

Supplemental Material

  • Figures
  • Tables
  • FIG S1

    Bacterial DNA found in negative controls. The overall number of 6 no-template controls (water instead of MEF subjected to extraction and all subsequent analytic steps) was expanded into 17 control positions in the second round of amplification. Data presented here are collapsed back into the six original samples. Download FIG S1, PDF file, 0.1 MB.

    Copyright © 2017 Sillanpää et al.

    This content is distributed under the terms of the Creative Commons Attribution 4.0 International license .

  • TABLE S1

    Primers used for verification of selected OTUs found in 16S profiles from the present study. Download TABLE S1, PDF file, 0.05 MB.

    Copyright © 2017 Sillanpää et al.

    This content is distributed under the terms of the Creative Commons Attribution 4.0 International license .

PreviousNext
Back to top
Download PDF
Citation Tools
Next-Generation Sequencing Combined with Specific PCR Assays To Determine the Bacterial 16S rRNA Gene Profiles of Middle Ear Fluid Collected from Children with Acute Otitis Media
Saara Sillanpää, Lenka Kramna, Sami Oikarinen, Markku Sipilä, Markus Rautiainen, Janne Aittoniemi, Jussi Laranne, Heikki Hyöty, Ondrej Cinek
mSphere Mar 2017, 2 (2) e00006-17; DOI: 10.1128/mSphere.00006-17

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print
Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this mSphere article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Next-Generation Sequencing Combined with Specific PCR Assays To Determine the Bacterial 16S rRNA Gene Profiles of Middle Ear Fluid Collected from Children with Acute Otitis Media
(Your Name) has forwarded a page to you from mSphere
(Your Name) thought you would be interested in this article in mSphere.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Next-Generation Sequencing Combined with Specific PCR Assays To Determine the Bacterial 16S rRNA Gene Profiles of Middle Ear Fluid Collected from Children with Acute Otitis Media
Saara Sillanpää, Lenka Kramna, Sami Oikarinen, Markku Sipilä, Markus Rautiainen, Janne Aittoniemi, Jussi Laranne, Heikki Hyöty, Ondrej Cinek
mSphere Mar 2017, 2 (2) e00006-17; DOI: 10.1128/mSphere.00006-17
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • RESULTS
    • DISCUSSION
    • MATERIALS AND METHODS
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

16S profiling
acute otitis media
bacteriome profiling
mass sequencing
next-generation sequencing

Related Articles

Cited By...

About

  • About mSphere
  • Board of Editors
  • Policies
  • For Reviewers
  • For the Media
  • Embargo Policy
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Author Warranty
  • Types of Articles
  • Getting Started
  • Ethics
  • Contact Us

Follow #mSphereJ

@ASMicrobiology

       

 

Website feedback

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Online ISSN: 2379-5042